Bolt Biotherapeutics Inc (BOLT)
0.6203
+0.04
(+6.31%)
USD |
NASDAQ |
Sep 27, 16:00
0.6588
+0.04
(+6.21%)
After-Hours: 20:00
Bolt Biotherapeutics Research and Development Expense (Annual): 61.54M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 61.54M |
| December 31, 2022 | 73.12M |
| December 31, 2021 | 75.66M |
| Date | Value |
|---|---|
| December 31, 2020 | 40.36M |
| December 31, 2019 | 26.00M |
| December 31, 2018 | 9.42M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
26.00M
Minimum
2019
75.66M
Maximum
2021
55.34M
Average
61.54M
Median
2023
Research and Development Expense (Annual) Benchmarks
| SeaStar Medical Holding Corp | 5.973M |
| CVS Health Corp | -- |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.63M |
| iBio Inc | 5.185M |